Essential Planning LLC. boosted its position in shares of Sharps Technology, Inc. (NASDAQ:STSS – Free Report) by 22.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 199,854 shares of the company’s stock after purchasing an additional 37,029 shares during the period. Essential Planning LLC. owned 3.63% of Sharps Technology worth $412,000 at the end of the most recent reporting period.
Separately, Garden State Investment Advisory Services LLC bought a new stake in Sharps Technology in the third quarter worth $26,000. Institutional investors and hedge funds own 17.17% of the company’s stock.
Sharps Technology Stock Performance
Sharps Technology stock opened at $0.37 on Friday. The firm has a market cap of $2.03 million, a price-to-earnings ratio of -0.05 and a beta of 1.47. Sharps Technology, Inc. has a fifty-two week low of $0.25 and a fifty-two week high of $18.15. The stock’s fifty day moving average price is $0.92.
Sharps Technology Profile
Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.
Featured Articles
- Five stocks we like better than Sharps Technology
- The Basics of Support and Resistance
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Business Services Stocks Investing
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How to Profit From Growth Investing
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Sharps Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Technology and related companies with MarketBeat.com's FREE daily email newsletter.
